# Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen

> **NCT00919919** · PHASE2 · UNKNOWN · sponsor: **Rabin Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Endometrial Hyperplasia
- Endometrial Cancer

## Interventions

- **DRUG:** progesterone
- **DRUG:** activella

## Key facts

- **NCT ID:** NCT00919919
- **Lead sponsor:** Rabin Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-06
- **Primary completion:** 2010-09
- **Final completion:** 2010-11
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2009-06-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00919919

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00919919, "Efficacy and Tolerability Study of Progesterone Vaginal Tablets (Endometrin®) in Menopausal Women Treated by Estrogen". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00919919. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*